ABSTRACT
Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, is a condition characterized by abnormal blood clot formation in the pulmonary arteries and the deep venous vasculature. It is often serious and sometimes even fatal if not promptly and appropriately treated. Moreover, the later consequences of VTE may result in reduced quality of life. The treatment of VTE depends on various factors, including the type, cause, and patient comorbidities. Furthermore, bleeding may occur as a side effect of VTE treatment. Thus, it is necessary to carefully weigh the benefits versus the risks of VTE treatment and to actively monitor patients undergoing treatment. Asian populations are known to have lower VTE incidences than Western populations, but recent studies have shown an increase in the incidence of VTE in Asia. A variety of treatment options are currently available owing to the introduction of direct oral anticoagulants.The current VTE treatment recommendation is based on evidence from previous studies, but it should be applied with careful consideration of the racial, genetic, and social characteristics in the Korean population.
ABSTRACT
Subject(s)
Female , Humans , Male , Bone Marrow , Diagnosis , Fluorescence , In Situ Hybridization , Korea , Leukemia , Leukemia, Promyelocytic, Acute , Microsatellite Repeats , Peripheral Blood Stem Cell Transplantation , Polymorphism, Single Nucleotide , Stem Cell Transplantation , Tandem Repeat Sequences , Tissue Donors , Y ChromosomeABSTRACT
BACKGROUND: Flow cytometry analysis of paroxysmal nocturnal hemoglobinuria (PNH) is significantly affected by the methodology used. The lack of data on the effect of age and refrigeration on PNH clone stability motivated us to study these aspects using flow cytometry. METHODS: Peripheral blood was collected from six patients, of which two presented with PNH. All samples were tested immediately and stored at room temperature (RT, 20–25℃) and at 4℃ for re-analysis at 24, 48, 72 hr and 7 days. Anti-CD59-fluorescein isothiocyanate (Beckman Coulter, USA) and anti-CD235a-phycoerythrin (PE; Beckman Coulter) were used to stain red blood cells (RBCs). Fluorescein-labeled proaerolysin (Cedarlane, Canada), anti-CD15-PE (Beckman Coulter), anti-CD24-PE-cyanin 5 (Beckman Coulter), and anti-CD45-PE-cyanin 7 (Beckman Coulter) were used to stain granulocytes. Flow cytometry was performed using a FC500 flow cytometer (Beckman Coulter). The effects of time and temperature were analyzed using generalized estimating equations. RESULTS: No significant differences in the gated percentage of RBCs and PNH clone size of RBCs were observed between the RT and 4℃ groups up to 7 days of testing. The percentage of gated neutrophils decreased with specimen age (P<0.001) and a better correlation with baseline was obtained at 4℃ than at RT (P=0.014). Neutrophil PNH clones were stable until 48 hr and 72 hr at RT and 4℃, respectively, and could not be analyzed at 7 days. CONCLUSIONS: RBC analysis was successfully performed up to 7 days. For neutrophils, testing within 48 hr is recommended, because the number of gated cells decreases significantly with age.
Subject(s)
Humans , Clone Cells , Erythrocytes , Flow Cytometry , Granulocytes , Hemoglobinuria, Paroxysmal , Neutrophils , RefrigerationABSTRACT
Lymphoplasmacytic lymphoma (LPL) is a low-grade B-cell neoplasm, composed of small B lymphocytes, plasmacytoid lymphocytes, and plasma cells, usually involving bone marrow and sometimes lymph nodes or spleen. LPL with bone marrow involvement and an IgM monoclonal gammopathy of any concentration is designated as Waldenström macroglobulinemia (WM). LPL associated with non-IgM monoclonal gammopathy or biclonal gammopathy is rarely observed. LPL diagnosis was based on clinical, morphological, and immunophenotypic findings. Recently, the test for L265P mutation of the myeloid differentiation factor 88 (MYD88) gene has been helpful in the diagnosis of LPL. Here, we reported the first case of LPL/WM with IgM-κ/IgA-λ biclonal gammopathy in Korea.
Subject(s)
B-Lymphocytes , Bone Marrow , Diagnosis , Immunoglobulin M , Korea , Lymph Nodes , Lymphocytes , Lymphoma , Multiple Myeloma , Myeloid Differentiation Factor 88 , Paraproteinemias , Plasma Cells , Spleen , Waldenstrom MacroglobulinemiaABSTRACT
BACKGROUND: Blood culture is a critical test for diagnosing bloodstream infections. Frequent microbial contamination during sampling and testing leads to abuse of antimicrobial agents. We evaluated methods for reducing contamination and obtaining more reliable results. METHODS: We analyzed blood cultures obtained between 2009 and 2015. We established 6 quality indicators: true positive rate, contamination rate, blood sampling volume, number of sets of blood cultures, delayed transportation rate, and percentage of samples collected from the femoral region, with reference to the CLSI guideline M47-A, 2007. Education was provided for interns and nurses responsible for blood sampling and transportation of specimens, and data were analyzed monthly. RESULTS: At baseline, the true positive rate was 12.8%, and the contamination rate was 4.0%. During the intervention period, these were decreased to 10.9% and 1.9%, respectively. The percentage of samples smaller than 5 mL decreased from 29.7% to 2.7-11.3%. The rate of one set of blood cultures being ordered was always <5%. The delayed transportation rate decreased from 35.6% to 5.5-7.7%. Finally, the percentage of samples collected from the femoral region decreased from 41.5% to 22.0-31.0%, because of which we did not attain our goal, 20.8%. CONCLUSION: The results showed improvements in contamination rate, specimen volume, specimen transportation time, and the percentage of samples collected from the femoral region. The quality management of blood cultures in 2011 was comparatively poor, which led to increased contamination rate, large number of samples containing <5 mL of blood, and increased percentage of samples collected from the femoral region. Thus, quality improvement methods can produce more reliable results of blood cultures.
Subject(s)
Anti-Infective Agents , Education , Femoral Artery , Femoral Vein , Quality Improvement , Quality Indicators, Health Care , TransportationABSTRACT
No abstract available.
Subject(s)
Female , Humans , Middle Aged , Base Sequence , Bone Marrow/pathology , DNA Mutational Analysis , Exons , Immunophenotyping , Leukemia, Mast-Cell/diagnosis , Mutation , Polymerase Chain Reaction , Proto-Oncogene Proteins c-kit/geneticsABSTRACT
BACKGROUND: Most immune reactions related to transfusion and transplantation are caused by IgM ABO antibodies. However, IgG also plays an important role in these reactions. Therefore, a method to measure antibodies, including IgG, is necessary. We investigated ABO antibody titers of healthy individuals using a column agglutination technique (CAT) with or without dithiothreitol (DTT) and compared them with titers obtained using a conventional tube method. METHODS: Among healthy adults who underwent a medical examination, 180 individuals (60 with blood group A, 60 with group B, and 60 with group O) were selected. Antibody titrations were performed using the immediate spin (IS) tube, anti-human globulin (AHG) tube, and CAT with or without DTT methods. RESULTS: Higher median values of anti-B and anti-A titers in groups A and B individuals, respectively, were obtained using the IS method than using the AHG method. Higher values for group O individuals were obtained using the AHG method. Higher median titers of anti-B and anti-A in group O individuals were obtained using CAT without DTT than using the AHG method. Median titers of anti-B and anti-A in all blood groups were higher in CAT without DTT than in CAT with DTT, especially for group O individuals. CONCLUSIONS: We recommend CAT with and without DTT for titration of anti-A and anti-B, especially in group O individuals, to provide more sensitive results that include IgG data. Adjustment of insurance coverage of fees associated with antibody titration might be necessary, considering the actual cost of reagents and personnel.
Subject(s)
Adult , Female , Humans , Male , Middle Aged , ABO Blood-Group System/immunology , Agglutination Tests/instrumentation , Antibodies/analysis , Immunoglobulin G/immunologyABSTRACT
BACKGROUND: Among the multitude of tests developed for the diagnosis of hepatitis C virus (HCV) infection, the enzyme immunoassay and the chemiluminescence immunoassays (CLIA) are the most commonly used. The OraQuick HCV Rapid Antibody Test is also popular because it can detect HCV antibodies from blood or saliva within 20 minutes. In this study, we compared the performances of the OraQuick HCV Rapid Antibody Test and CLIA in the diagnosis of HCV infection. METHODS: We tested 150 serum samples from Soonchunhyang University Seoul Hospital for HCV between November 2012 and January 2013 using CLIA (ADVIA Centaur) as well as the OraQuick test. The data from both tests were compared to the results of HCV real-time PCR (COBAS AmpliPrep/COBAS TaqMan HCV test kit). RESULTS: In the PCR analysis, 59 of the 150 samples (39.3%) tested positive and 91 (60.7%) tested negative for HCV RNA. All these samples also tested positive when screened by CLIA. However, only 57 of 59 samples tested positive with the OraQuick test. Among the 91 samples found to be HCV-negative in the PCR analysis, 50 tested negative in both CLIA and the OraQuick tests. However, a discrepancy was noted among the remaining 41 samples that tested HCV-negative in the PCR analysis; 21 of these samples tested positive in both CLIA and the OraQuick tests, but the remaining 20 tested positive only in CLIA. CONCLUSIONS: Although the OraQuick test showed a marginally lower sensitivity for HCV detection than CLIA, we conclude that it is still beneficial because it is rapid and can be performed using blood and saliva samples. Our findings suggest that the OraQuick test could be an important diagnostic tool for screening HCV infection.
Subject(s)
Diagnosis , Hepacivirus , Hepatitis C Antibodies , Hepatitis C , Hepatitis , Immunoassay , Immunoenzyme Techniques , Luminescence , Mass Screening , Polymerase Chain Reaction , Real-Time Polymerase Chain Reaction , RNA , Saliva , SeoulABSTRACT
Involvement of the central nervous system is very uncommon in multiple myeloma, observed in approximately 1% of the multiple myeloma patients. We report a case of central nervous system myelomatosis with complex chromosome aberrations in a 62-yr-old female patient, who had previously been diagnosed as multiple myeloma. Fluorescent in situ hybridization revealed 13q deletion, p53 gene deletion and IGH/FGFR3 rearrangement and chromosomal study showed complex chromosome aberrations. After four cycles of chemotherapy, the patient was admitted to the hematology department with severe headache. Plasma cells were found in the cerebrospinal fluid (CSF), and CSF immunoelectrophoresis revealed abnormal precipitin arcs against anti-IgG and anti-lambda antisera. She was given systemic chemotherapy and eight courses of intrathecal chemotherapy, which cleared plasma cells in the CSF. Two months later, she was given autologous stem cell transplantation. Three months after stem cell transplantation, central nervous system myelomatosis progressed to plasma cell leukemia and two months later,the patient expired.
Subject(s)
Female , Humans , Middle Aged , Antineoplastic Agents/therapeutic use , Central Nervous System Neoplasms/diagnosis , Cerebrospinal Fluid/cytology , Chromosome Deletion , Combined Modality Therapy , Disease Progression , Gene Deletion , Immunoelectrophoresis , In Situ Hybridization, Fluorescence , Leukemia, Plasma Cell/diagnosis , Multiple Myeloma/diagnosis , Plasma Cells/pathology , Precipitins/metabolism , Receptor, Fibroblast Growth Factor, Type 3/genetics , Stem Cell Transplantation , Translocation, Genetic , Transplantation, Autologous , Tumor Suppressor Protein p53/geneticsABSTRACT
BACKGROUND: In sepsis, large scale inflammatory responses can cause extensive collateral damage to the vasculature, because both coagulation and fibrinolysis are activated unevenly. Thrombin-activatable fibrinolysis inhibitor (TAFI) plays a role in modulating fibrinolysis. Since TAFI can be activated by both thrombin and plasmin, it is thought to be affected in sepsis. Hence, activated and inactivated TAFI (TAFIa/ai) may be used to monitor changes in sepsis. METHODS: TAFIa/ai-specific in-house ELISA can detect only the TAFIa/ai form, because the ELISA capture agent is potato tuber carboxypeptidase inhibitor (PTCI), which has selective affinity towards only the TAFIa and TAFIai isoforms. TAFIa/ai levels in plasma from 25 patients with sepsis and 19 healthy volunteers were quantitated with the in-house ELISA. RESULTS: We observed increased TAFIa/ai levels in samples from patients with sepsis (48.7+/-9.3 ng/mL) than in samples from healthy individuals (10.5+/-5.9 ng/mL). In contrast, no difference in total TAFI concentration was obtained between sepsis patients and healthy controls. The results suggest that TAFI zymogen was activated and that TAFIa/ai accumulated in sepsis. CONCLUSION: The detection of TAFIa/ai in plasma could provide a useful and simple diagnostic tool for sepsis. Uneven activation of both coagulation and fibrinolysis in sepsis could be caused by the activation of TAFI zymogen and elevation of TAFIa/ai. TAFIa/ai could be a novel marker to monitor sepsis and other blood-related disturbances.
Subject(s)
Humans , Carboxypeptidase B2 , Enzyme-Linked Immunosorbent Assay , Fibrinolysin , Fibrinolysis , Organothiophosphorus Compounds , Plasma , Protein Isoforms , Sepsis , Solanum tuberosum , ThrombinABSTRACT
BACKGROUND: The pandemic swine origin influenza A/H1N1 2009 virus (H1N1 2009) was rapidly spread out all over the world after it was first found in April, 2009. This study was made to compare the performance of nasopharyngeal swabs and nasopharyngeal aspirates for the SD Bioline rapid influenza antigen test. METHODS: From Aug to Nov, 2009 the SD Bioline rapid influenza antigen tests were conducted with the nasopharyngeal swabs and the nasopharyngeal aspirates from the 244 specimens of patients who had come to the hospital with influenza-like illness. The data from the examination were compared with the multiplex RT-PCR as a reference standard to obtain sensitivity, specificity, positive predictive value and negative predictive value. RESULTS: The sensitivity and the specificity of the SD Bioline rapid influenza antigen tests with the nasopharyngeal swabs were 75.8%, and 93.3% respectively, and the sensitivity and specificity with the nasopharyngeal aspirates were 61.3%, and 98.3% respectively. CONCLUSION: Even if the nasopharyngeal aspirates showed the lower sensitivity than the nasopharyngeal swabs, since the specificity is higher, the nasopharyngeal aspirates are more useful because we can reduce false positive rate.
Subject(s)
Humans , Influenza, Human , Pandemics , Sensitivity and Specificity , Swine , VirusesABSTRACT
This case study reports a rare fibrinogen variant, gamma Met310Thr mutation, for the first time in Korea. The case shows a point mutation from T to C in the 1,007th nucleotide of the FGG gene. This report describes a variant fibrinogen, hereinafter called "fibrinogen Yecheon", using the name after the town where the patient was living at the time of diagnosis. Fibrinogen Yecheon has a de novo heterozygous point mutation of FGG resulting in gamma Met310Thr and subsequent extra N-glycosylation at gamma Asn308. Extra N-glycosylated fibrinogen is considered a main inhibitor of normal fibrinogen activity.
Subject(s)
Humans , Male , Young Adult , Base Sequence , Blood Coagulation Disorders, Inherited/genetics , DNA Mutational Analysis , Fibrinogens, Abnormal/genetics , Korea , Methionine/genetics , Molecular Sequence Data , Point Mutation , Threonine/geneticsABSTRACT
BACKGROUND: Soon Chun Hyang University Hospital emergency laboratory introduced Cobas(R) 6000 (Roche Diagnostics, Switzerland) to improve the turnaround time of emergency chemistry tests at peak time period. METHODS: For the designated period, before and after introduction of Cobas(R) 6000 the numbers of tests and test time were compared and we analyzed the process of the tests using Workflow simulator (Roche Diagnostics). RESULTS: The numbers of tests of 8 days (every Monday and Thursday) in June, 2007 and 2008 were 22,902 and 27,384. The mean test time of the 8 days in June, 2007 and 2008 were 13 min 41 sec and 12 min 22 sec. In 2007, increased mean test time was due to prolongation of waiting times in rotor within equipment for tests at peak time period. CONCLUSIONS: Using Cobas(R) 6000, the numbers of tests were increased at peak time period but mean test time was reduced, which made physicians and laboratory all satisfied.
Subject(s)
Emergencies , WorkflowABSTRACT
We report a case of Anti-Jk(a), whose reactivity was abolished in an enzyme gel test. A 56-year-old woman was admitted to our hospital because of fever, myalgia, nausea and vomiting. Anti-Jk(a) was detected by antibody screening and an identification test using a LISS/Coombs gel card (DiaMed AG, Cressier sur Morat, Switzwerland). Its reactivity was so weak (trace ~ 1+) that an Enzyme gel card (DiaMed AG) was added to enhance the reactivity. Unexpectedly, all reactions with the enzyme-treated cells showed negative results. The patient's RBC phenotype was Jk(a-b+). The abdominal CT revealed a 6x7.5 cm sized liver abscess. Her condition improved after percutaneous catheter drainage and she was discharged on the 23rd hospital day.
Subject(s)
Female , Humans , Middle Aged , Catheters , Drainage , Fever , Liver Abscess , Mass Screening , Nausea , Phenotype , VomitingABSTRACT
BACKGROUND: For the diagnosis of HIV infection, enzyme immunoassay (EIA) or chemiluminescence immunoassay (CLIA) is commonly used as a screening test. Although these methods have a high sensitivity and low cost, their high false positive rate can cause confusion in the patients and clinicians until a more specific test is done. OraQuick Advance Rapid HIV-1/2 Antibody Test (OraQuick) (OraSure Technologies, USA) is a rapid test that can detect HIV-1/2 antibodies in 20 minutes. It uses oral fluid, whole blood or serum sample. In this study, we evaluated the usefulness of the OraQuick as a screening and point-of-care test for HIV infection. METHODS: From Jan 2007 to Dec 2008, 45,276 samples referred to our laboratory were tested by CLIA method using the ADVIA Centaur (Bayer Healthcare LTD., USA) for HIV-1/2 antibody detection. Among them, 74 positive and 50 negative samples were tested by the Western immunoblot assay (WIB) and OraQuick test as a case-control study. Also, oral fluids from 30 HIV patients and 48 healthy persons were tested by OraQuick test. RESULTS: The sensitivity and specificity of OraQuick test (using serum samples) were 100% and 98.8% (95% confidence interval 96.9~100%), respectively. OraQuick tests (using oral fluid samples) were all positive for HIV patients but all negative for healthy persons. CONCLUSIONS: This study suggests that OraQuick can be used successfully as a rapid test for the early detection of HIV-1/2 antibody in patients visiting emergency departments and for the prevention of HIV infection in the health care providers.
Subject(s)
Humans , Antibodies , Blotting, Western , Case-Control Studies , Delivery of Health Care , Emergencies , HIV , HIV Infections , Immunoassay , Immunoenzyme Techniques , Infection Control , Luminescence , Mass Screening , Sensitivity and SpecificityABSTRACT
BACKGROUND: The number of people infected with human immunodeficiency virus (HIV) continues to grow globally. Because HIV infection can be transmitted not only by sexual contact but by transfusion, the performance of diagnostic tests can not be overemphasized. However, sometimes false positive results accompanied by high sensitivity of screening tests can confuse both doctors and patients. The present study determined the positive and false positive rates from a large data set. METHODS: From May 2005 to Dec 2008, HIV screening tests were performed with samples obtained from 77,562 patients by ADVIA Centaur (Bayer Health Care LLC, Tarrytown, NY, USA). Positive samples were referred to the Seoul Research Institute of Public Health and Environment for Western immunoblot (WIB) assays. Medical records were reviewed in patients with false positive screening results. RESULTS: The number of patients with a positive screening test was 117 of 77,562 (0.15%). Among these, 56 were positive with WIB (0.07%), producing a positive predictive value for the screening test of 47.9% (56/117). Diagnoses of patients with false positive results were mainly inflammatory diseases such as chronic hepatitis, renal failure, tuberculosis and sexually transmitted diseases. Also, 12 healthy persons referred for regular medical checkup produced false positive RESULTS. CONCLUSION: Positive rates of HIV tests and diagnoses relevant with false positive screening RESULTS could provide useful information to medical personnel for diagnosis and consultation of HIV infection.
Subject(s)
Humans , Academies and Institutes , Blotting, Western , Delivery of Health Care , Diagnostic Tests, Routine , Hepatitis, Chronic , HIV , HIV Infections , Mass Screening , Medical Records , Public Health , Renal Insufficiency , Sexually Transmitted Diseases , Tertiary Healthcare , TuberculosisABSTRACT
We report a case of multiple myeloma showing marked differences in serum Immunoglobulin G (IgG) levels between serum protein electrophoresis and turbidimetry. A 47-yr old man was admitted to our hospital due to severe back pain and diagnosed as having IgG-kappa type multiple myeloma. Serum protein level was 14.4 g/dL at the time of diagnosis. Serum IgG level was 8.5 g/dL by serum protein electrophoresis, but 11.6 g/dL by turbidimetry. The patient's clinical conditions had improved after receiving VAD (vincristine, adriamycin, dexamethasone) and VTD (vincristine, thalidomide, dexamethasone) chemotherapy and there were no differences in IgG levels between electrophoresis and turbidimetry when serum IgG levels were less than 3.0 g/dL. According to this, we considered that both protein electrophoresis and turbidimetry should be needed to quantify serum immunoglobulins for diagnosis and follow-up of the patients with monoclonal gammopathy.